WILLIAM M. BENNETT, M.D.; JOSEPH P. PULLIAM, M.D.
This content is PDF only. Please click on the PDF icon to access.
Cyclosporine is a potent new immunosuppressive agent that selectively inhibits T-cell function, allowing survival of allografts without myelosuppression. Its use should minimize the many adverse effects of long-term steroid therapy. Although the long-term effects of cyclosporine on renal allograft longevity are not well documented, enthusiastic reports in the medical literature and lay press have led to an unprecedented anticipation by prospective allograft recipients, particularly patients with chronic renal failure receiving long-term dialysis. However, these reports have not sufficiently emphasized the nephrotoxicity that frequently accompanies cyclosporine therapy.
Cyclosporine is a lipophilic molecule with a molecular weight of 1202 daltons. When the
BENNETT WM, PULLIAM JP. Cyclosporine Nephrotoxicity. Ann Intern Med. 1983;99:851–854. doi: 10.7326/0003-4819-99-6-851
Download citation file:
Published: Ann Intern Med. 1983;99(6):851-854.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use